TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23686130

Group type: EXPERIMENTAL
Intervention: REHACOP (neuropsychological rehabilitation)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 84
Study: 21394496

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 529

Group type: COMPARATOR
Intervention: Control
Number of subjects: 529
Study: 19639511

Group type: COMPARATOR
Intervention: Vaginal delivery (VD)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Caesarean section (CS)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Negative previous birth experience
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Previous CS
Number of subjects: 201
Study: 17316466

Group type: EXPERIMENTAL
Intervention: Continuous infusion of hydrocortisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bolus application of hydrocortisone
Number of subjects: 0
Study: 14684673

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiazide diuretics
Number of subjects: 0
Study: 11455143

Group type: EXPERIMENTAL
Intervention: Combination therapy (topical corticosteroid + barrier cream)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Topical corticosteroid
Number of subjects: 14

Group type: COMPARATOR
Intervention: Barrier cream
Number of subjects: 14

Group type: COMPARATOR
Intervention: No treatment (fourth patch)
Number of subjects: 14
Study: 10050213

Group type: EXPERIMENTAL
Intervention: Embolization
Number of subjects: 387

Group type: COMPARATOR
Intervention: Microsurgery or radiosurgery
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Atraumatic superselective microcatheterization
Number of subjects: 387
Study: 8014444

Group type: EXPERIMENTAL
Intervention: Propylthiouracil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2513047

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (active treatment)
Number of subjects: 19000

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19000
Study: 785427

Group type: EXPERIMENTAL
Intervention: Adsorbed surface-antigen influenza vaccine
Number of subjects: 0
Study: 30859320

Group type: EXPERIMENTAL
Intervention: Exercise protocol inducing DOMS (trunk flexion-extension in a prone position with loads corresponding to participant's trunk weight plus 10% of their trunk extension maximal voluntary contraction)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise protocol inducing DOMS
Number of subjects: 24
Study: 27871927

Group type: EXPERIMENTAL
Intervention: Active pulsed magnetic stimulation (16 sessions over 2 months)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Active pulsed magnetic stimulation (32 sessions total)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Active pulsed magnetic stimulation (16 sessions)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No active pulsed magnetic stimulation (control)
Number of subjects: 120
Study: 25900027

Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 40
Study: 24021959

Group type: EXPERIMENTAL
Intervention: Selegiline transdermal system (STS) 6 mg/24h
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo (PLB)
Number of subjects: 322
Study: 21240530

Group type: EXPERIMENTAL
Intervention: Surgical treatment (undercutting laminectomy augmented with transpedicular-instrumented fusion)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 94
Study: 18430318

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Pranlukast
Number of subjects: 85

Group type: COMPARATOR
Intervention: Discontinuation of treatment
Number of subjects: 85
Study: 16878682

Group type: EXPERIMENTAL
Intervention: Monochromatic phototherapy (Biolight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12640556

Group type: EXPERIMENTAL
Intervention: Patlak graphical analysis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simplified kinetic method (SKM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SUV (normalised for lean body mass and with a correction for plasma glucose)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SUV-based net influx constant
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Total lesion evaluation (TLE)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SUV (normalised for body surface area)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 6P model
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tumour to non-tumour ratio (TNT)
Number of subjects: 20
Study: 11524464

Group type: EXPERIMENTAL
Intervention: Mylan extended-release phenytoin sodium capsules with food
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dilantin Kapseals with food
Number of subjects: 24
Study: 9159703

Group type: EXPERIMENTAL
Intervention: Repetitive follow-up laboratory and radiologic testing (except for nonseminomatous germ cell tumors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Limited panel of blood tests and radiographic studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: More restrictive policy of follow-up testing
Number of subjects: 0
Study: 8320940

Group type: EXPERIMENTAL
Intervention: AN 69 membrane
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cuprophan
Number of subjects: 54
Study: 3098255

Group type: EXPERIMENTAL
Intervention: Rioprostil 50 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Rioprostil 100 micrograms
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31446180

Group type: EXPERIMENTAL
Intervention: Genotype analysis for NUDT15, FTO, and TPMT variants; patients heterozygous for any variant received 50 mg azathioprine equivalents, homozygous patients received alternative drugs; those without variants and non-genotyping group received 50 mg azathioprine equivalents with dose escalation.
Number of subjects: 164

Group type: COMPARATOR
Intervention: Non-genotyping group (no genotype analysis); received 50 mg azathioprine equivalents followed by dose escalation.
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Genotype analysis (pretreatment)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Maximum dose of thiopurines
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Genotype analysis
Number of subjects: 164
Study: 27232208

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy
Number of subjects: 156

Group type: COMPARATOR
Intervention: Therapy as usual
Number of subjects: 156
Study: 28673741

Group type: EXPERIMENTAL
Intervention: CBT-T
Number of subjects: 141

Group type: COMPARATOR
Intervention: NST-T
Number of subjects: 141
Study: 26625869

Group type: EXPERIMENTAL
Intervention: BIP ETT (n=20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard ETT (n=10)
Number of subjects: 30
Study: 24007717

Group type: EXPERIMENTAL
Intervention: Atorvastatin (AT, n=17)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT, n=34)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Hormone Therapy plus Atorvastatin (HT+AT, n=36)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Hormone Therapy (HT)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Atorvastatin (AT)
Number of subjects: 87
Study: 20100811

Group type: EXPERIMENTAL
Intervention: 200 mg alagebrium twice daily
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 18166796

Group type: EXPERIMENTAL
Intervention: TAD (thalidomide, doxorubicin, dexamethasone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: VAD (vincristine, adriamycin, dexamethasone)
Number of subjects: 0
Study: 16386450

Group type: EXPERIMENTAL
Intervention: Deep abdominal muscle contractions (TrA and IO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle (PFM) strength assessment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ability to voluntarily contract deep abdominal muscles
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Strength of pelvic floor muscles (PFMs)
Number of subjects: 20
Study: 15000272

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg b.i.d.
Number of subjects: 647

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 647
Study: 11270018

Group type: EXPERIMENTAL
Intervention: Hypertonic saline 7.5%
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% saline (Control)
Number of subjects: 40
Study: 9296424

Group type: EXPERIMENTAL
Intervention: Desflurane (DES)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Isoflurane (ISO)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Propofol (PRO)
Number of subjects: 45
Study: 8376696

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 3536262

Group type: EXPERIMENTAL
Intervention: Physical therapy plus salmon calcitonin 100 MRC units daily for 3 weeks (Group II)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Physical therapy alone (Group I)
Number of subjects: 24
Study: 31952916

Group type: COMPARATOR
Intervention: Conventional Cawthorne & Cooksey protocol (n = 40)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Multimodal Cawthorne & Cooksey protocol (n = 42)
Number of subjects: 82
Study: 29032769

Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: 20 mg d-amphetamine
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 27885290

Group type: EXPERIMENTAL
Intervention: Spinal Anaesthesia (SA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: General Anaesthesia (GA)
Number of subjects: 120
Study: 24721024

Group type: EXPERIMENTAL
Intervention: Procedural sedation analgesia (SA) with ketamine 1 to 2 mg/kg intravenously
Number of subjects: 41

Group type: COMPARATOR
Intervention: Suprascapular nerve block (SNB) under ultrasound guidance
Number of subjects: 41

Group type: COMPARATOR
Intervention: Procedural sedation analgesia (SA)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SNB)
Number of subjects: 41
Study: 22349708

Group type: EXPERIMENTAL
Intervention: Unpredictable shocks (US‐only group)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Explicitly unpaired presentations of a neutral shape and the shock (Unpaired group)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Paired shape‐shock presentations (Paired group)
Number of subjects: 3
Study: 20450757

Group type: EXPERIMENTAL
Intervention: Post-abortion counseling and education (PACE)
Number of subjects: 189

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 189
Study: 18028472

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (46‐50 Gy) and surgery
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation and surgery
Number of subjects: 150
Study: 11465654

Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Losartan (50 mg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Lisinopril and Losartan
Number of subjects: 33
Study: 9629934

Group type: EXPERIMENTAL
Intervention: Functional restoration (FR) program
Number of subjects: 238

Group type: COMPARATOR
Intervention: Non-treated control group
Number of subjects: 238

Group type: COMPARATOR
Intervention: Less intensive treatment programs
Number of subjects: 238
Study: 8185007

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 2896556

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol (beta 1-selective blocker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol (nonselective beta-blocker)
Number of subjects: 0
Study: 31650217

Group type: EXPERIMENTAL
Intervention: PET-MR enterography without bowel purgation
Number of subjects: 50

Group type: COMPARATOR
Intervention: PET-MR enterography with bowel purgation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MR morphological parameters (MRmorph)
Number of subjects: 50
Study: 30289485

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (25 mg DPV)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 96
Study: 28391798

Group type: EXPERIMENTAL
Intervention: Diab (health video game)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 179
Study: 25615629

Group type: EXPERIMENTAL
Intervention: Prefix 750 (750 μg/cm(3) granules)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prefix 150 (150 μg/cm(3) granules)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (autogenous iliac crest bone graft, ICBG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (ICBG)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prefix 750
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prefix 150
Number of subjects: 24
Study: 24199982

Group type: EXPERIMENTAL
Intervention: Conventional periodontal treatment (CPT) and homeopathic medicine (HM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional periodontal treatment (CPT)
Number of subjects: 60
Study: 21606877

Group type: EXPERIMENTAL
Intervention: Cooling collar from the start (CC)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Cooling collar replaced at 30‐min intervals (CC(replaced))
Number of subjects: 7

Group type: COMPARATOR
Intervention: No collar (NC)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Cooling collar (CC)
Number of subjects: 7
Study: 18342185

Group type: EXPERIMENTAL
Intervention: Trospium 60 mg QD
Number of subjects: 564

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 564
Study: 16540862

Group type: EXPERIMENTAL
Intervention: Chiropractic care without physical therapy or modalities
Number of subjects: 681

Group type: COMPARATOR
Intervention: Medical care without physical therapy
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Medical care with physical therapy
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Chiropractic care
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Chiropractic and physical therapy
Number of subjects: 681

Group type: COMPARATOR
Intervention: Medical care only
Number of subjects: 681
Study: 12653262

Group type: EXPERIMENTAL
Intervention: Tacrolimus and low-dose prednisolone
Number of subjects: 23
Study: 10634337

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) programs
Number of subjects: 1356

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1356
Study: 9190976

Group type: EXPERIMENTAL
Intervention: rHuEPO (150 U/kg body wt, sc three times a week for 12 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: rHuEPO (responders)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: rHuEPO and Placebo
Number of subjects: 35
Study: 1347205

Group type: EXPERIMENTAL
Intervention: Pipecuronium 0.06 mg.kg-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vecuronium 0.2 mg.kg-1
Number of subjects: 0
Study: 31767584

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary resuscitation
Number of subjects: 40

Group type: COMPARATOR
Intervention: No cardiopulmonary resuscitation
Number of subjects: 40
Study: 29789925

Group type: EXPERIMENTAL
Intervention: CYP2D6 gene rs28371725 CC and CT genotypes in PPE
Number of subjects: 208

Group type: COMPARATOR
Intervention: CYP2D6 gene rs1065852 nonresponsive to labetalol
Number of subjects: 208
Study: 26885316

Group type: EXPERIMENTAL
Intervention: Drinking black coffee three or more times per day
Number of subjects: 3497

Group type: EXPERIMENTAL
Intervention: Drinking black coffee
Number of subjects: 3497

Group type: COMPARATOR
Intervention: Mixing creamer and sugar into coffee
Number of subjects: 3497
Study: 24460860

Group type: EXPERIMENTAL
Intervention: Accurate estimation of drinker type
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: Underestimation of drinker type
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: Overestimation of drinker type
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: Positive alcohol expectancies, protective and risky drinking behaviors, descriptive peer norms
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: Protective and risky drinking behaviors
Number of subjects: 1895
Study: 23217093

Group type: EXPERIMENTAL
Intervention: Short-term psychodynamic psychotherapy (up to 20 + 5 sessions)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Treatment as usual (augmented by recommendation for counseling center and physician information)
Number of subjects: 180
Study: 20571894

Group type: EXPERIMENTAL
Intervention: IL-2 treatment
Number of subjects: 0
Study: 20307440

Group type: EXPERIMENTAL
Intervention: Bedscapes + standard care
Number of subjects: 152

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 152
Study: 16394300

Group type: EXPERIMENTAL
Intervention: Intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel
Number of subjects: 415

Group type: COMPARATOR
Intervention: Intravenous paclitaxel plus cisplatin
Number of subjects: 415
Study: 12651033

Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy
Number of subjects: 2201

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2201
Study: 10848537

Group type: EXPERIMENTAL
Intervention: Glibenclamide (5 mg po)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Insulin (0.3 mU.kg(‐1).min(‐1) iv)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nicorandil (40 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glibenclamide (5 mg) or Nicorandil (40 mg) or Glibenclamide and Nicorandil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypercapnia
Number of subjects: 10
Study: 8869800

Group type: EXPERIMENTAL
Intervention: Prophylactic or pre‐emptive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empiric therapy for febrile episodes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre‐emptive therapy
Number of subjects: 0
Study: 1323974

Group type: EXPERIMENTAL
Intervention: Recombinant interferon beta serine (12 x 10(6) U, nasal drops, three times daily for 4.3 days)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (nasal drops, three times daily for 4.3 days)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Recombinant interferon beta serine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 6721016

Group type: EXPERIMENTAL
Intervention: Home health aides offered to patients
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control group (no aides)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Home health aides accepted by 44 patients
Number of subjects: 227
Study: 31847912

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) testing
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Enhanced communication skills with patient leaflets
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Combined interventions (CRP testing + enhanced communication skills)
Number of subjects: 2940

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2940
Study: 29775959

Group type: EXPERIMENTAL
Intervention: Cigarettes with 15.8 mg/g nicotine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cigarettes with 5.2 mg/g nicotine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cigarettes with 1.3 mg/g nicotine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cigarettes with 0.4 mg/g nicotine
Number of subjects: 50
Study: 27434595

Group type: EXPERIMENTAL
Intervention: Strontium-89 (Sr-89) with docetaxel
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA) with docetaxel
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Generic Zoledronic acid (ZA) with docetaxel
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Proprietary Zoledronic acid (ZA) with docetaxel
Number of subjects: 757

Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 757
Study: 24464687

Group type: EXPERIMENTAL
Intervention: Low Ejection Fraction (LVEF < 40%)
Number of subjects: 7007

Group type: EXPERIMENTAL
Intervention: Intermediate Ejection Fraction (LVEF 40-50%)
Number of subjects: 7007

Group type: EXPERIMENTAL
Intervention: Preserved Ejection Fraction (LVEF > 50%)
Number of subjects: 7007

Group type: EXPERIMENTAL
Intervention: LVEF as a continuous variable
Number of subjects: 7007

Group type: COMPARATOR
Intervention: Multivariable adjustment for LowEF
Number of subjects: 7007

Group type: COMPARATOR
Intervention: Multivariable adjustment for IntEF
Number of subjects: 7007
Study: 22824768

Group type: EXPERIMENTAL
Intervention: Iron supplementation and anti-H. pylori therapy (Group I)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Iron supplementation only (Group II)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 20
Study: 18330516

Group type: EXPERIMENTAL
Intervention: Full perfusion (APS 10-12)
Number of subjects: 168
Study: 17804905

Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 627

Group type: COMPARATOR
Intervention: Aspirin therapy
Number of subjects: 627
Study: 15248226

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg subcutaneously twice weekly for 24 weeks
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 11755921

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 9659650

Group type: EXPERIMENTAL
Intervention: Carbetocin (100 micrograms intravenous injection)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Oxytocin (continuous 16 hour infusion)
Number of subjects: 57
Study: 7806654

Group type: EXPERIMENTAL
Intervention: Role playing scenarios
Number of subjects: 0
Study: 2534405

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) at 0.005 microgram/kg per min
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: D-sulpiride at 0.05 mg/kg per min
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) + D-sulpiride at the same doses
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (saline for 60 min)
Number of subjects: 7